CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL
Exhibit 10.2
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL
July 19, 2023
Xxxxxx X. Xxxx
[*]
Re: Terms of Separation
This letter confirms the agreement (“Agreement”) between you and Passage Bio, Inc. (the “Company”) concerning the terms of your separation and offers you the separation compensation we discussed in exchange for a general release of claims and covenant not to sue.
By signing below, you expressly acknowledge that the Separation Benefits fully satisfy any and all (i) severance obligations the Company may have to you under Section 5 of the Amended and Restated Employment Agreement that you entered into with the Company on August 23, 2021 (the “Employment Agreement”) or otherwise, and (ii) retention obligations the Company may have to you under the Retention Memo.
c. You and the Company do not intend to release claims that you may not release as a matter of law, including but not limited to claims for indemnity, or any claims for enforcement of this Agreement. To the fullest extent permitted by law, any dispute regarding the scope of this general release shall be determined by an arbitrator under the procedures set forth in the arbitration clause below.
If you agree to abide by the terms outlined in this Agreement, please sign and return it to me. I wish you the best in your future endeavors.
Sincerely,
By: /s/ Xxxx Xxxx
Xxxx Xxxx, MD
President and Chief Executive Officer
READ, UNDERSTOOD AND AGREED
/s/ Xxxxxx Xxxx Date: 07/19/2023
Xxxxxx X. Xxxx
EXHIBIT A
Employee Invention Assignment, Confidentiality, and Non-Competition Agreement
[*]
EXHIBIT B
OPTION AMENDMENT
[*]